Catalyst Wire Dossier Catalyst Wire Dossier

RC010 inhalation powder

RC010 · Nanjing Reju Therapeutics Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for RC010 inhalation powder, covering 2026-04-14 to 2026-04-14. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Study to Evaluate the Safety, Tolerability and Pharmacokinetic Characteristics of RC010 Inhalation Powder in Healthy Participants [Phase 1]

See pricing